PD/Cub |
serum free fatty acids level |
fasting (for 16 hours) |
Seda O, et al., Physiol Genomics. 2005 Apr 14;21(2):243-52. Epub 2005 Feb 22. |
blood free fatty acid amount |
male |
300 days
| 6 |
|
1.05 |
mmol/l |
0.04 |
0.1 |
liquid phase colorimetry |
retroorbital plexus |
0.0 |
0 |
|
|
70228 |
1318 |
BN/Cub |
serum triglyceride level |
fasting (for 16 hours) |
Seda O, et al., Physiol Genomics. 2005 Apr 14;21(2):243-52. Epub 2005 Feb 22. |
blood triglyceride amount |
male |
300 days
| 6 |
|
47.79 |
mg/dl |
3.61 |
8.85 |
liquid phase colorimetry |
retroorbital plexus |
0.0 |
0 |
|
|
70214 |
1318 |
PD/Cub |
serum uric acid level |
fasting (for 16 hours) |
Seda O, et al., Physiol Genomics. 2005 Apr 14;21(2):243-52. Epub 2005 Feb 22. |
blood uric acid amount |
male |
300 days
| 6 |
|
66.6 |
umol/l |
0.57 |
1.4 |
liquid phase colorimetry |
retroorbital plexus |
0.0 |
0 |
|
|
70280 |
1318 |
BN/Cub |
serum uric acid level |
fasting (for 16 hours) |
Seda O, et al., Physiol Genomics. 2005 Apr 14;21(2):243-52. Epub 2005 Feb 22. |
blood uric acid amount |
male |
300 days
| 6 |
|
72.3 |
umol/l |
1.55 |
3.8 |
liquid phase colorimetry |
retroorbital plexus |
0.0 |
0 |
|
|
70281 |
1318 |
BN/Cub |
serum uric acid level |
controlled sucrose content diet (for 7 days) then dexamethasone (0.03 mg/ml) (for 3 days) then fasting (for 16 hours) |
Seda O, et al., Physiol Genomics. 2005 Apr 14;21(2):243-52. Epub 2005 Feb 22. |
blood uric acid amount |
male |
310 days
| 6 |
|
107.3 |
umol/l |
3.18 |
7.8 |
liquid phase colorimetry |
retroorbital plexus |
0.0 |
0 |
|
|
70285 |
1318 |
Hsd:WI |
serum total protein level |
bisphenol A (125 mg/kg/d) (for 91 days) |
Yildiz N and Barlas N, Hum Exp Toxicol. 2013 Jul;32(7):675-86. doi: 10.1177/0960327112464796. |
blood total protein amount |
male |
119 days-126 days |
6 |
|
8.68 |
g/dl |
0.78 |
1.9 |
liquid phase colorimetry |
|
0.0 |
0 |
|
|
76126 |
1545 |
Crl:SD |
plasma glucose level |
control condition |
Verma S, et al., J Pharmacol Exp Ther. 1994 Dec;271(3):1334-7. |
blood glucose amount |
male |
63 days-77 days |
8 |
|
111.6 |
mg/dl |
1.8 |
5.09 |
liquid phase colorimetry |
|
0.0 |
0 |
|
C |
75856 |
1540 |
Crl:SD |
plasma glucose level |
controlled metformin content drinking water (350-500 mg/kg/d) (between 21 and 35 days) |
Verma S, et al., J Pharmacol Exp Ther. 1994 Dec;271(3):1334-7. |
blood glucose amount |
male |
63 days-77 days |
8 |
|
111.6 |
mg/dl |
5.4 |
15.27 |
liquid phase colorimetry |
|
0.0 |
0 |
|
CT |
75858 |
1540 |
Hsd:WI |
serum calcium level |
vehicle control condition (for 91 days) |
Yildiz N and Barlas N, Hum Exp Toxicol. 2013 Jul;32(7):675-86. doi: 10.1177/0960327112464796. |
blood calcium amount |
male |
119 days-126 days |
5 |
|
12.82 |
mg/dl |
0.24 |
0.53 |
liquid phase colorimetry |
|
0.0 |
0 |
|
|
76141 |
1545 |
Hsd:WI |
serum albumin level |
vehicle control condition (for 91 days) |
Yildiz N and Barlas N, Hum Exp Toxicol. 2013 Jul;32(7):675-86. doi: 10.1177/0960327112464796. |
blood albumin amount |
male |
119 days-126 days |
5 |
|
0.04 |
g/dl |
0.0 |
0.0 |
liquid phase colorimetry |
|
0.0 |
0 |
|
|
76149 |
1545 |
Hsd:WI |
serum albumin level |
bisphenol A (125 mg/kg/d) (for 91 days) |
Yildiz N and Barlas N, Hum Exp Toxicol. 2013 Jul;32(7):675-86. doi: 10.1177/0960327112464796. |
blood albumin amount |
male |
119 days-126 days |
6 |
|
0.05 |
g/dl |
0.0 |
0.01 |
liquid phase colorimetry |
|
0.0 |
0 |
|
|
76150 |
1545 |
Hsd:WI |
serum creatinine level |
bisphenol A (125 mg/kg/d) (for 91 days) |
Yildiz N and Barlas N, Hum Exp Toxicol. 2013 Jul;32(7):675-86. doi: 10.1177/0960327112464796. |
blood creatinine amount |
male |
119 days-126 days |
6 |
|
0.65 |
mg/dl |
0.03 |
0.08 |
liquid phase colorimetry |
|
0.0 |
0 |
|
|
76171 |
1545 |
Hsd:WI |
plasma creatinine level |
cisplatin (3 mg/kg) (for 25 days) and benfotiamine (100 mg/kg/d) (for 25 days) |
Harisa GI J Biochem Mol Toxicol. 2013 Aug;27(8):398-405. doi: 10.1002/jbt.21501. Epub 2013 May 28. |
blood creatinine amount |
male |
0 days
| 8 |
|
1.67 |
mg/dl |
0.12 |
0.33 |
liquid phase colorimetry |
|
0.0 |
0 |
|
|
75946 |
1542 |
Hsd:WI |
plasma uric acid level |
cisplatin (3 mg/kg) (for 25 days) and benfotiamine (100 mg/kg/d) (for 25 days) |
Harisa GI J Biochem Mol Toxicol. 2013 Aug;27(8):398-405. doi: 10.1002/jbt.21501. Epub 2013 May 28. |
blood uric acid amount |
male |
0 days
| 8 |
|
4.89 |
mg/dl |
0.35 |
0.98 |
liquid phase colorimetry |
|
0.0 |
0 |
|
|
75950 |
1542 |
Hsd:WI |
kidney superoxide dismutase activity to total protein level ratio |
cisplatin (3 mg/kg) (for 25 days) |
Harisa GI J Biochem Mol Toxicol. 2013 Aug;27(8):398-405. doi: 10.1002/jbt.21501. Epub 2013 May 28. |
kidney superoxide dismutase activity |
male |
0 days
| 8 |
|
450.1 |
U/mg |
3.15 |
8.91 |
liquid phase colorimetry |
|
0.0 |
0 |
|
|
76201 |
1542 |
Hsd:WI |
kidney catalase activity to total protein level ratio |
vehicle control condition (for 10 days) then cisplatin (7.5 mg/kg) |
Prabhu VV, et al., Pharmacol Rep. 2013;65(4):980-90. |
catalase activity |
male |
0 days
| 6 |
|
21.73 |
nmol/mg |
0.62 |
1.51 |
liquid phase colorimetry |
|
0.0 |
0 |
|
|
76235 |
1544 |
Hsd:WI |
kidney glutathione peroxidase activity to glutathione reductase activity ratio |
cisplatin (3 mg/kg) (for 25 days) |
Harisa GI J Biochem Mol Toxicol. 2013 Aug;27(8):398-405. doi: 10.1002/jbt.21501. Epub 2013 May 28. |
kidney glutathione peroxidase activity |
male |
0 days
| 8 |
|
62.54 |
null |
2.21 |
6.24 |
liquid phase colorimetry |
|
0.0 |
0 |
|
|
76215 |
1542 |
Hsd:WI |
kidney superoxide dismutase to catalase activity ratio |
cisplatin (3 mg/kg) (for 25 days) |
Harisa GI J Biochem Mol Toxicol. 2013 Aug;27(8):398-405. doi: 10.1002/jbt.21501. Epub 2013 May 28. |
kidney superoxide dismutase activity |
male |
0 days
| 8 |
|
6.67 |
null |
0.3 |
0.85 |
liquid phase colorimetry |
|
0.0 |
0 |
|
|
76219 |
1542 |
Jcl:WI |
serum total cholesterol level |
control condition |
Akiyama S, et al., Biosci Biotechnol Biochem. 2009 Dec;73(12):2779-82. doi: 10.1271/bbb.90576. Epub 2009 Dec 7. |
blood cholesterol amount |
male |
52 days
| 6 |
|
80.7 |
mg/dl |
6.58 |
16.12 |
liquid phase colorimetry |
|
0.0 |
0 |
|
|
103962 |
2884 |
GK/Jcl |
serum total cholesterol level |
control condition |
Akiyama S, et al., Biosci Biotechnol Biochem. 2009 Dec;73(12):2779-82. doi: 10.1271/bbb.90576. Epub 2009 Dec 7. |
blood cholesterol amount |
male |
52 days
| 6 |
|
182.95 |
mg/dl |
5.35 |
13.1 |
liquid phase colorimetry |
|
0.0 |
0 |
|
|
103963 |
2884 |
Jcl:WI |
serum high density lipoprotein cholesterol level to serum total cholesterol level ratio |
control condition |
Akiyama S, et al., Biosci Biotechnol Biochem. 2009 Dec;73(12):2779-82. doi: 10.1271/bbb.90576. Epub 2009 Dec 7. |
blood cholesterol amount |
male |
52 days
| 6 |
|
0.81 |
null |
0.02 |
0.05 |
liquid phase colorimetry |
|
0.0 |
0 |
|
|
103966 |
2884 |
GK/Jcl |
liver cholesterol level |
controlled hesperidin content diet (1 %) (for 28 days) |
Akiyama S, et al., Biosci Biotechnol Biochem. 2009 Dec;73(12):2779-82. doi: 10.1271/bbb.90576. Epub 2009 Dec 7. |
liver cholesterol amount |
male |
52 days
| 6 |
|
1.82 |
mg/g |
0.13 |
0.32 |
liquid phase colorimetry |
|
0.0 |
0 |
|
|
103976 |
2884 |
GK/Jcl |
liver cholesterol level |
controlled cyclodextrin (CD)-clathrated hesperetin content diet (4.6 %) (for 28 days) |
Akiyama S, et al., Biosci Biotechnol Biochem. 2009 Dec;73(12):2779-82. doi: 10.1271/bbb.90576. Epub 2009 Dec 7. |
liver cholesterol amount |
male |
52 days
| 6 |
|
1.67 |
mg/g |
0.06 |
0.15 |
liquid phase colorimetry |
|
0.0 |
0 |
|
|
103977 |
2884 |
MWF |
renal plasma flow |
castor oil |
Fassi A, etal., Am J Kidney Dis. 1999 Feb;33(2):267-75. doi: 10.1016/s0272-6386(99)70299-4. |
kidney plasma flow trait |
male |
133 days-147 days |
7 |
|
3.73 |
ml/min |
0.35 |
0.93 |
liquid phase colorimetry |
|
0.0 |
0 |
|
|
110082 |
3163 |
MWF |
renal filtration fraction |
castor oil |
Fassi A, etal., Am J Kidney Dis. 1999 Feb;33(2):267-75. doi: 10.1016/s0272-6386(99)70299-4. |
glomerular filtration trait |
male |
133 days-147 days |
7 |
|
0.25 |
null |
0.03 |
0.08 |
liquid phase colorimetry |
|
0.0 |
0 |
|
|
110085 |
3163 |
Hsd:WI |
plasma urea nitrogen level |
benfotiamine (100 mg/kg/d) (for 25 days) |
Harisa GI J Biochem Mol Toxicol. 2013 Aug;27(8):398-405. doi: 10.1002/jbt.21501. Epub 2013 May 28. |
blood urea nitrogen amount |
male |
0 days
| 8 |
|
8.05 |
mmol/l |
0.44 |
1.25 |
liquid phase colorimetry |
|
0.0 |
0 |
|
|
75940 |
1542 |
Hsd:WI |
serum total cholesterol level |
vehicle control condition (for 91 days) |
Yildiz N and Barlas N, Hum Exp Toxicol. 2013 Jul;32(7):675-86. doi: 10.1177/0960327112464796. |
blood cholesterol amount |
male |
119 days-126 days |
5 |
|
68.12 |
mg/dl |
6.42 |
14.36 |
liquid phase colorimetry |
|
0.0 |
0 |
|
|
76130 |
1545 |
Hsd:WI |
serum urea nitrogen level |
bisphenol A (125 mg/kg/d) (for 91 days) |
Yildiz N and Barlas N, Hum Exp Toxicol. 2013 Jul;32(7):675-86. doi: 10.1177/0960327112464796. |
blood urea nitrogen amount |
male |
119 days-126 days |
6 |
|
80.85 |
mg/dl |
3.23 |
7.92 |
liquid phase colorimetry |
|
0.0 |
0 |
|
|
76165 |
1545 |
Hsd:WI |
serum urea nitrogen level |
octylphenol (125 mg/kg/d) (for 91 days) |
Yildiz N and Barlas N, Hum Exp Toxicol. 2013 Jul;32(7):675-86. doi: 10.1177/0960327112464796. |
blood urea nitrogen amount |
male |
119 days-126 days |
6 |
|
76.42 |
mg/dl |
4.07 |
9.96 |
liquid phase colorimetry |
|
0.0 |
0 |
|
|
76167 |
1545 |
Hsd:WI |
kidney glutathione level |
1H-pyrazole (10 mg/kg/d) (for 10 days) then cisplatin (7.5 mg/kg) |
Prabhu VV, et al., Pharmacol Rep. 2013;65(4):980-90. |
kidney glutathione amount |
male |
0 days
| 6 |
|
10012.49 |
ug/g |
293.58 |
719.13 |
liquid phase colorimetry |
|
0.0 |
0 |
|
|
76240 |
1544 |
Hsd:WI |
kidney glutathione peroxidase activity to glutathione reductase activity ratio |
cisplatin (3 mg/kg) (for 25 days) and benfotiamine (100 mg/kg/d) (for 25 days) |
Harisa GI J Biochem Mol Toxicol. 2013 Aug;27(8):398-405. doi: 10.1002/jbt.21501. Epub 2013 May 28. |
kidney glutathione peroxidase activity |
male |
0 days
| 8 |
|
46.14 |
null |
1.7 |
4.82 |
liquid phase colorimetry |
|
0.0 |
0 |
|
|
76216 |
1542 |
Hsd:WI |
kidney superoxide dismutase to catalase activity ratio |
benfotiamine (100 mg/kg/d) (for 25 days) |
Harisa GI J Biochem Mol Toxicol. 2013 Aug;27(8):398-405. doi: 10.1002/jbt.21501. Epub 2013 May 28. |
kidney superoxide dismutase activity |
male |
0 days
| 8 |
|
1.93 |
null |
0.07 |
0.2 |
liquid phase colorimetry |
|
0.0 |
0 |
|
|
76218 |
1542 |
PD/Cub |
serum triglyceride level |
controlled sucrose content diet (for 7 days) then fasting (for 16 hours) |
Seda O, et al., Physiol Genomics. 2005 Apr 14;21(2):243-52. Epub 2005 Feb 22. |
blood triglyceride amount |
male |
307 days
| 6 |
|
276.99 |
mg/dl |
43.35 |
106.2 |
liquid phase colorimetry |
retroorbital plexus |
0.0 |
0 |
|
|
70215 |
1318 |
Hsd:WI |
kidney superoxide dismutase to catalase activity ratio |
cisplatin (3 mg/kg) (for 25 days) and benfotiamine (100 mg/kg/d) (for 25 days) |
Harisa GI J Biochem Mol Toxicol. 2013 Aug;27(8):398-405. doi: 10.1002/jbt.21501. Epub 2013 May 28. |
kidney superoxide dismutase activity |
male |
0 days
| 8 |
|
2.92 |
null |
0.11 |
0.32 |
liquid phase colorimetry |
|
0.0 |
0 |
|
|
76220 |
1542 |
Hsd:WI |
serum urea nitrogen level |
1H-pyrazole (10 mg/kg/d) (for 10 days) then cisplatin (7.5 mg/kg) |
Prabhu VV, et al., Pharmacol Rep. 2013;65(4):980-90. |
blood urea nitrogen amount |
male |
0 days
| 6 |
|
89.7 |
mg/dl |
2.9 |
7.11 |
liquid phase colorimetry |
|
0.0 |
0 |
|
|
75978 |
1544 |
PD/Cub |
serum triglyceride level |
fasting (for 16 hours) |
Seda O, et al., Physiol Genomics. 2005 Apr 14;21(2):243-52. Epub 2005 Feb 22. |
blood triglyceride amount |
male |
300 days
| 6 |
|
178.76 |
mg/dl |
18.06 |
44.25 |
liquid phase colorimetry |
retroorbital plexus |
0.0 |
0 |
|
|
70213 |
1318 |
BN/Cub |
serum triglyceride level |
controlled sucrose content diet (for 7 days) then fasting (for 16 hours) |
Seda O, et al., Physiol Genomics. 2005 Apr 14;21(2):243-52. Epub 2005 Feb 22. |
blood triglyceride amount |
male |
307 days
| 6 |
|
61.95 |
mg/dl |
7.23 |
17.7 |
liquid phase colorimetry |
retroorbital plexus |
0.0 |
0 |
|
|
70216 |
1318 |
BN/Cub |
serum triglyceride level |
controlled sucrose content diet (for 7 days) then dexamethasone (0.03 mg/ml) (for 3 days) then fasting (for 16 hours) |
Seda O, et al., Physiol Genomics. 2005 Apr 14;21(2):243-52. Epub 2005 Feb 22. |
blood triglyceride amount |
male |
310 days
| 6 |
|
46.9 |
mg/dl |
3.61 |
8.85 |
liquid phase colorimetry |
retroorbital plexus |
0.0 |
0 |
|
|
70220 |
1318 |
PD/Cub |
serum uric acid level |
controlled sucrose content diet (for 7 days) then fasting (for 16 hours) |
Seda O, et al., Physiol Genomics. 2005 Apr 14;21(2):243-52. Epub 2005 Feb 22. |
blood uric acid amount |
male |
307 days
| 6 |
|
110.2 |
umol/l |
2.49 |
6.1 |
liquid phase colorimetry |
retroorbital plexus |
0.0 |
0 |
|
|
70282 |
1318 |
Hsd:WI |
kidney glutathione peroxidase activity to total protein level ratio |
vehicle control condition (for 10 days) |
Prabhu VV, et al., Pharmacol Rep. 2013;65(4):980-90. |
kidney glutathione peroxidase activity |
male |
0 days
| 6 |
|
22.63 |
U/mg |
1.35 |
3.3 |
liquid phase colorimetry |
|
0.0 |
0 |
|
|
76191 |
1544 |
Hsd:WI |
kidney glutathione peroxidase activity to total protein level ratio |
vehicle control condition (for 10 days) then cisplatin (7.5 mg/kg) |
Prabhu VV, et al., Pharmacol Rep. 2013;65(4):980-90. |
kidney glutathione peroxidase activity |
male |
0 days
| 6 |
|
7.54 |
U/mg |
0.51 |
1.24 |
liquid phase colorimetry |
|
0.0 |
0 |
|
|
76192 |
1544 |
Hsd:WI |
kidney glutathione peroxidase activity to total protein level ratio |
silymarin (50 mg/kg/d) (for 10 days) then cisplatin (7.5 mg/kg) |
Prabhu VV, et al., Pharmacol Rep. 2013;65(4):980-90. |
kidney glutathione peroxidase activity |
male |
0 days
| 6 |
|
15.4 |
U/mg |
0.29 |
0.71 |
liquid phase colorimetry |
|
0.0 |
0 |
|
|
76194 |
1544 |
Hsd:WI |
serum total protein level |
vehicle control condition (for 91 days) |
Yildiz N and Barlas N, Hum Exp Toxicol. 2013 Jul;32(7):675-86. doi: 10.1177/0960327112464796. |
blood total protein amount |
male |
119 days-126 days |
5 |
|
9.38 |
g/dl |
0.67 |
1.5 |
liquid phase colorimetry |
|
0.0 |
0 |
|
|
76125 |
1545 |
Hsd:WI |
serum total cholesterol level |
bisphenol A (125 mg/kg/d) (for 91 days) |
Yildiz N and Barlas N, Hum Exp Toxicol. 2013 Jul;32(7):675-86. doi: 10.1177/0960327112464796. |
blood cholesterol amount |
male |
119 days-126 days |
6 |
|
66.62 |
mg/dl |
5.62 |
13.77 |
liquid phase colorimetry |
|
0.0 |
0 |
|
|
76131 |
1545 |
Crl:SD |
plasma glucose level |
controlled fructose content diet (66 %) |
Verma S, et al., J Pharmacol Exp Ther. 1994 Dec;271(3):1334-7. |
blood glucose amount |
male |
42 days
| 9 |
|
108.0 |
mg/dl |
1.8 |
5.4 |
liquid phase colorimetry |
|
0.0 |
0 |
|
F |
75859 |
1540 |
Crl:SD |
plasma glucose level |
control condition |
Verma S, et al., J Pharmacol Exp Ther. 1994 Dec;271(3):1334-7. |
blood glucose amount |
male |
42 days
| 8 |
|
118.8 |
mg/dl |
5.4 |
15.27 |
liquid phase colorimetry |
|
0.0 |
0 |
|
C |
75860 |
1540 |
Hsd:WI |
plasma urea nitrogen level |
phosphate buffered saline (for 25 days) |
Harisa GI J Biochem Mol Toxicol. 2013 Aug;27(8):398-405. doi: 10.1002/jbt.21501. Epub 2013 May 28. |
blood urea nitrogen amount |
male |
0 days
| 8 |
|
8.7 |
mmol/l |
0.47 |
1.34 |
liquid phase colorimetry |
|
0.0 |
0 |
|
|
75939 |
1542 |
Hsd:WI |
serum triglyceride level |
bisphenol A (125 mg/kg/d) (for 91 days) |
Yildiz N and Barlas N, Hum Exp Toxicol. 2013 Jul;32(7):675-86. doi: 10.1177/0960327112464796. |
blood triglyceride amount |
male |
119 days-126 days |
6 |
|
116.97 |
mg/dl |
7.02 |
17.2 |
liquid phase colorimetry |
|
0.0 |
0 |
|
|
76136 |
1545 |
Hsd:WI |
serum calcium level |
bisphenol A (125 mg/kg/d) (for 91 days) |
Yildiz N and Barlas N, Hum Exp Toxicol. 2013 Jul;32(7):675-86. doi: 10.1177/0960327112464796. |
blood calcium amount |
male |
119 days-126 days |
6 |
|
12.93 |
mg/dl |
0.78 |
1.91 |
liquid phase colorimetry |
|
0.0 |
0 |
|
|
76142 |
1545 |
Hsd:WI |
serum albumin level |
octylphenol (250 mg/kg/d) (for 91 days) |
Yildiz N and Barlas N, Hum Exp Toxicol. 2013 Jul;32(7):675-86. doi: 10.1177/0960327112464796. |
blood albumin amount |
male |
119 days-126 days |
6 |
|
0.04 |
g/dl |
0.0 |
0.0 |
liquid phase colorimetry |
|
0.0 |
0 |
|
|
76153 |
1545 |
Hsd:WI |
serum total bilirubin level |
bisphenol A (250 mg/kg/d) (for 91 days) |
Yildiz N and Barlas N, Hum Exp Toxicol. 2013 Jul;32(7):675-86. doi: 10.1177/0960327112464796. |
blood bilirubin amount |
male |
119 days-126 days |
6 |
|
0.75 |
mg/dl |
0.26 |
0.64 |
liquid phase colorimetry |
|
0.0 |
0 |
|
|
76158 |
1545 |
Hsd:WI |
serum urea nitrogen level |
octylphenol (250 mg/kg/d) (for 91 days) |
Yildiz N and Barlas N, Hum Exp Toxicol. 2013 Jul;32(7):675-86. doi: 10.1177/0960327112464796. |
blood urea nitrogen amount |
male |
119 days-126 days |
6 |
|
72.18 |
mg/dl |
5.06 |
12.4 |
liquid phase colorimetry |
|
0.0 |
0 |
|
|
76168 |
1545 |
Hsd:WI |
serum creatinine level |
bisphenol A (250 mg/kg/d) (for 91 days) |
Yildiz N and Barlas N, Hum Exp Toxicol. 2013 Jul;32(7):675-86. doi: 10.1177/0960327112464796. |
blood creatinine amount |
male |
119 days-126 days |
6 |
|
0.65 |
mg/dl |
0.03 |
0.08 |
liquid phase colorimetry |
|
0.0 |
0 |
|
|
76172 |
1545 |
Hsd:WI |
serum lactate dehydrogenase activity level |
vehicle control condition (for 91 days) |
Yildiz N and Barlas N, Hum Exp Toxicol. 2013 Jul;32(7):675-86. doi: 10.1177/0960327112464796. |
blood lactate dehydrogenase amount |
male |
119 days-126 days |
5 |
|
1068.0 |
U/l |
313.23 |
700.4 |
liquid phase colorimetry |
|
0.0 |
0 |
|
|
76177 |
1545 |
Hsd:WI |
plasma creatinine level |
phosphate buffered saline (for 25 days) |
Harisa GI J Biochem Mol Toxicol. 2013 Aug;27(8):398-405. doi: 10.1002/jbt.21501. Epub 2013 May 28. |
blood creatinine amount |
male |
0 days
| 8 |
|
0.31 |
mg/dl |
0.02 |
0.05 |
liquid phase colorimetry |
|
0.0 |
0 |
|
|
75943 |
1542 |
Hsd:WI |
kidney paraoxonase1 activity to total protein level ratio |
phosphate buffered saline (for 25 days) |
Harisa GI J Biochem Mol Toxicol. 2013 Aug;27(8):398-405. doi: 10.1002/jbt.21501. Epub 2013 May 28. |
kidney paraoxonase 1 activity |
male |
0 days
| 8 |
|
17.25 |
U/mg |
0.61 |
1.73 |
liquid phase colorimetry |
|
0.0 |
0 |
|
|
76209 |
1542 |
Hsd:WI |
kidney superoxide dismutase activity to total protein level ratio |
benfotiamine (100 mg/kg/d) (for 25 days) |
Harisa GI J Biochem Mol Toxicol. 2013 Aug;27(8):398-405. doi: 10.1002/jbt.21501. Epub 2013 May 28. |
kidney superoxide dismutase activity |
male |
0 days
| 8 |
|
242.2 |
U/mg |
5.3 |
15.0 |
liquid phase colorimetry |
|
0.0 |
0 |
|
|
76200 |
1542 |
Hsd:WI |
kidney superoxide dismutase activity to total protein level ratio |
silymarin (50 mg/kg/d) (for 10 days) then cisplatin (7.5 mg/kg) |
Prabhu VV, et al., Pharmacol Rep. 2013;65(4):980-90. |
kidney superoxide dismutase activity |
male |
0 days
| 6 |
|
11.74 |
U/mg |
0.56 |
1.38 |
liquid phase colorimetry |
|
0.0 |
0 |
|
|
76190 |
1544 |
Hsd:WI |
kidney superoxide dismutase to paraoxonase1 activity ratio |
cisplatin (3 mg/kg) (for 25 days) |
Harisa GI J Biochem Mol Toxicol. 2013 Aug;27(8):398-405. doi: 10.1002/jbt.21501. Epub 2013 May 28. |
kidney superoxide dismutase activity |
male |
0 days
| 8 |
|
47.04 |
null |
2.0 |
5.65 |
liquid phase colorimetry |
|
0.0 |
0 |
|
|
76227 |
1542 |
GK/Jcl |
serum total cholesterol level |
controlled hesperidin content diet (1 %) (for 28 days) |
Akiyama S, et al., Biosci Biotechnol Biochem. 2009 Dec;73(12):2779-82. doi: 10.1271/bbb.90576. Epub 2009 Dec 7. |
blood cholesterol amount |
male |
52 days
| 6 |
|
117.47 |
mg/dl |
4.36 |
10.68 |
liquid phase colorimetry |
|
0.0 |
0 |
|
|
103964 |
2884 |
SD-Abcc6em2Qlju+/+ |
serum phosphate level to plasma pyrophosphate level ratio |
standard diet |
Li Q, et al., J Invest Dermatol. 2017 May;137(5):1025-1032. doi: 10.1016/j.jid.2016.11.042. Epub 2017 Jan 19. |
blood pyrophosphate amount |
female |
60 days-180 days |
5 |
|
558.9 |
null |
97.9 |
218.91 |
liquid phase colorimetry |
|
0.0 |
0 |
|
|
104661 |
2972 |
SD-Abcc6em2Qlju-/- |
serum phosphate level to plasma pyrophosphate level ratio |
standard diet |
Li Q, et al., J Invest Dermatol. 2017 May;137(5):1025-1032. doi: 10.1016/j.jid.2016.11.042. Epub 2017 Jan 19. |
blood pyrophosphate amount |
male |
60 days-180 days |
5 |
|
2082.3 |
null |
626.9 |
1401.79 |
liquid phase colorimetry |
|
0.0 |
0 |
|
|
104664 |
2972 |
SD-Abcc6em2Qlju+/- |
serum phosphate level |
standard diet |
Li Q, et al., J Invest Dermatol. 2017 May;137(5):1025-1032. doi: 10.1016/j.jid.2016.11.042. Epub 2017 Jan 19. |
blood phosphate amount |
female |
60 days-180 days |
5 |
|
5.7 |
mg/dl |
0.1 |
0.22 |
liquid phase colorimetry |
|
0.0 |
0 |
|
|
104645 |
2972 |
Hsd:WI |
serum creatinine level |
vehicle control condition (for 91 days) |
Yildiz N and Barlas N, Hum Exp Toxicol. 2013 Jul;32(7):675-86. doi: 10.1177/0960327112464796. |
blood creatinine amount |
male |
119 days-126 days |
5 |
|
0.68 |
mg/dl |
0.05 |
0.11 |
liquid phase colorimetry |
|
0.0 |
0 |
|
|
76170 |
1545 |
Hsd:WI |
serum lactate dehydrogenase activity level |
bisphenol A (125 mg/kg/d) (for 91 days) |
Yildiz N and Barlas N, Hum Exp Toxicol. 2013 Jul;32(7):675-86. doi: 10.1177/0960327112464796. |
blood lactate dehydrogenase amount |
male |
119 days-126 days |
6 |
|
754.8 |
U/l |
112.47 |
275.5 |
liquid phase colorimetry |
|
0.0 |
0 |
|
|
76178 |
1545 |
Hsd:WI |
serum lactate dehydrogenase activity level |
octylphenol (250 mg/kg/d) (for 91 days) |
Yildiz N and Barlas N, Hum Exp Toxicol. 2013 Jul;32(7):675-86. doi: 10.1177/0960327112464796. |
blood lactate dehydrogenase amount |
male |
119 days-126 days |
6 |
|
919.2 |
U/l |
186.98 |
458.0 |
liquid phase colorimetry |
|
0.0 |
0 |
|
|
76181 |
1545 |
Hsd:WI |
kidney catalase activity to total protein level ratio |
vehicle control condition (for 10 days) |
Prabhu VV, et al., Pharmacol Rep. 2013;65(4):980-90. |
catalase activity |
male |
0 days
| 6 |
|
35.98 |
nmol/mg |
0.81 |
1.98 |
liquid phase colorimetry |
|
0.0 |
0 |
|
|
76234 |
1544 |
BN/Cub |
serum free fatty acids level |
controlled sucrose content diet (for 7 days) then dexamethasone (0.03 mg/ml) (for 3 days) then fasting (for 16 hours) |
Seda O, et al., Physiol Genomics. 2005 Apr 14;21(2):243-52. Epub 2005 Feb 22. |
blood free fatty acid amount |
male |
310 days
| 6 |
|
1.4 |
mmol/l |
0.08 |
0.2 |
liquid phase colorimetry |
retroorbital plexus |
0.0 |
0 |
|
|
70235 |
1318 |
SD-Abcc6em2Qlju+/+ |
serum phosphate level to plasma pyrophosphate level ratio |
standard diet |
Li Q, et al., J Invest Dermatol. 2017 May;137(5):1025-1032. doi: 10.1016/j.jid.2016.11.042. Epub 2017 Jan 19. |
blood pyrophosphate amount |
male |
60 days-180 days |
5 |
|
455.3 |
null |
54.2 |
121.19 |
liquid phase colorimetry |
|
0.0 |
0 |
|
|
104660 |
2972 |
Hsd:WI |
kidney glutathione level |
benfotiamine (100 mg/kg/d) (for 25 days) |
Harisa GI J Biochem Mol Toxicol. 2013 Aug;27(8):398-405. doi: 10.1002/jbt.21501. Epub 2013 May 28. |
kidney glutathione amount |
male |
0 days
| 8 |
|
126.5 |
ug/g |
1.5 |
4.23 |
liquid phase colorimetry |
|
0.0 |
0 |
|
|
76230 |
1542 |
SD-Abcc6em2Qlju+/- |
serum phosphate level to plasma pyrophosphate level ratio |
standard diet |
Li Q, et al., J Invest Dermatol. 2017 May;137(5):1025-1032. doi: 10.1016/j.jid.2016.11.042. Epub 2017 Jan 19. |
blood pyrophosphate amount |
male |
60 days-180 days |
5 |
|
820.6 |
null |
144.1 |
322.22 |
liquid phase colorimetry |
|
0.0 |
0 |
|
|
104662 |
2972 |
PD/Cub |
serum uric acid level |
controlled sucrose content diet (for 7 days) then dexamethasone (0.03 mg/ml) (for 3 days) then fasting (for 16 hours) |
Seda O, et al., Physiol Genomics. 2005 Apr 14;21(2):243-52. Epub 2005 Feb 22. |
blood uric acid amount |
male |
310 days
| 6 |
|
67.2 |
umol/l |
2.53 |
6.2 |
liquid phase colorimetry |
retroorbital plexus |
0.0 |
0 |
|
|
70284 |
1318 |
SHR.PD-(D8Mgh9-D8Rat149)/Cub |
serum free fatty acids level |
fasting (for 16 hours) |
Seda O, et al., Physiol Genomics. 2005 Apr 14;21(2):243-52. Epub 2005 Feb 22. |
blood free fatty acid amount |
male |
0 days
| 6 |
|
1.58 |
mmol/l |
0.04 |
0.09 |
liquid phase colorimetry |
retroorbital plexus |
0.0 |
0 |
|
|
70289 |
1318 |
F344/NHsd |
inflammatory exudate nitric oxide level |
room temperature (14 ml) (for 3 days) then room temperature (10 ml) (for 3 days) then carrageenan (1 ml) (for 6 hours) |
Laragione T, et al., J Immunol. 2007 Feb 15;178(4):2344-51. |
nitric oxide amount |
female |
56 days-98 days |
10 |
median |
0.12 |
umol/l |
|
|
liquid phase colorimetry |
subcutaneous interscapular cavity |
0.0 |
0 |
Griess test |
inflammatory exudate nitric oxide measurement |
68404 |
332 |
DA.F344-(D8Arb15-D8Arb22)/Arb |
inflammatory exudate nitric oxide level |
room temperature (14 ml) (for 3 days) then room temperature (10 ml) (for 3 days) then carrageenan (1 ml) (for 6 hours) |
Laragione T, et al., J Immunol. 2007 Feb 15;178(4):2344-51. |
nitric oxide amount |
female |
56 days-98 days |
14 |
median |
0.16 |
umol/l |
|
|
liquid phase colorimetry |
subcutaneous interscapular cavity |
0.0 |
0 |
Griess test |
inflammatory exudate nitric oxide measurement |
68405 |
332 |
Hsd:WI |
serum total protein level |
octylphenol (125 mg/kg/d) (for 91 days) |
Yildiz N and Barlas N, Hum Exp Toxicol. 2013 Jul;32(7):675-86. doi: 10.1177/0960327112464796. |
blood total protein amount |
male |
119 days-126 days |
6 |
|
8.18 |
g/dl |
0.21 |
0.52 |
liquid phase colorimetry |
|
0.0 |
0 |
|
|
76128 |
1545 |
Hsd:WI |
serum total cholesterol level |
bisphenol A (250 mg/kg/d) (for 91 days) |
Yildiz N and Barlas N, Hum Exp Toxicol. 2013 Jul;32(7):675-86. doi: 10.1177/0960327112464796. |
blood cholesterol amount |
male |
119 days-126 days |
6 |
|
56.48 |
mg/dl |
4.25 |
10.4 |
liquid phase colorimetry |
|
0.0 |
0 |
|
|
76132 |
1545 |
Hsd:WI |
kidney glutathione peroxidase activity to total protein level ratio |
1H-pyrazole (10 mg/kg/d) (for 10 days) then cisplatin (7.5 mg/kg) |
Prabhu VV, et al., Pharmacol Rep. 2013;65(4):980-90. |
kidney glutathione peroxidase activity |
male |
0 days
| 6 |
|
13.39 |
U/mg |
0.09 |
0.21 |
liquid phase colorimetry |
|
0.0 |
0 |
|
|
76193 |
1544 |
Crl:SD |
plasma glucose level |
controlled metformin content drinking water (350-500 mg/kg/d) |
Verma S, et al., J Pharmacol Exp Ther. 1994 Dec;271(3):1334-7. |
blood glucose amount |
male |
42 days
| 8 |
|
106.2 |
mg/dl |
9.0 |
25.46 |
liquid phase colorimetry |
|
0.0 |
0 |
|
CT |
75862 |
1540 |
Hsd:WI |
kidney lipid peroxide level |
vehicle control condition (for 10 days) |
Prabhu VV, et al., Pharmacol Rep. 2013;65(4):980-90. |
kidney lipid peroxide amount |
male |
0 days
| 6 |
|
0.75 |
nmol/mg |
0.02 |
0.04 |
liquid phase colorimetry |
|
0.0 |
0 |
|
|
76256 |
1544 |
Hsd:WI |
kidney paraoxonase1 activity to total protein level ratio |
cisplatin (3 mg/kg) (for 25 days) |
Harisa GI J Biochem Mol Toxicol. 2013 Aug;27(8):398-405. doi: 10.1002/jbt.21501. Epub 2013 May 28. |
kidney paraoxonase 1 activity |
male |
0 days
| 8 |
|
9.57 |
U/mg |
0.3 |
0.86 |
liquid phase colorimetry |
|
0.0 |
0 |
|
|
76211 |
1542 |
Hsd:WI |
serum calcium level |
octylphenol (125 mg/kg/d) (for 91 days) |
Yildiz N and Barlas N, Hum Exp Toxicol. 2013 Jul;32(7):675-86. doi: 10.1177/0960327112464796. |
blood calcium amount |
male |
119 days-126 days |
6 |
|
12.98 |
mg/dl |
0.42 |
1.04 |
liquid phase colorimetry |
|
0.0 |
0 |
|
|
76144 |
1545 |
Hsd:WI |
serum total bilirubin level |
bisphenol A (125 mg/kg/d) (for 91 days) |
Yildiz N and Barlas N, Hum Exp Toxicol. 2013 Jul;32(7):675-86. doi: 10.1177/0960327112464796. |
blood bilirubin amount |
male |
119 days-126 days |
6 |
|
0.6 |
mg/dl |
0.13 |
0.32 |
liquid phase colorimetry |
|
0.0 |
0 |
|
|
76157 |
1545 |
Hsd:WI |
serum total bilirubin level |
octylphenol (250 mg/kg/d) (for 91 days) |
Yildiz N and Barlas N, Hum Exp Toxicol. 2013 Jul;32(7):675-86. doi: 10.1177/0960327112464796. |
blood bilirubin amount |
male |
119 days-126 days |
6 |
|
0.55 |
mg/dl |
0.08 |
0.21 |
liquid phase colorimetry |
|
0.0 |
0 |
|
|
76160 |
1545 |
Hsd:WI |
serum lactate dehydrogenase activity level |
bisphenol A (250 mg/kg/d) (for 91 days) |
Yildiz N and Barlas N, Hum Exp Toxicol. 2013 Jul;32(7):675-86. doi: 10.1177/0960327112464796. |
blood lactate dehydrogenase amount |
male |
119 days-126 days |
6 |
|
1036.8 |
U/l |
158.11 |
387.3 |
liquid phase colorimetry |
|
0.0 |
0 |
|
|
76179 |
1545 |
Hsd:WI |
kidney glutathione level |
cisplatin (3 mg/kg) (for 25 days) and benfotiamine (100 mg/kg/d) (for 25 days) |
Harisa GI J Biochem Mol Toxicol. 2013 Aug;27(8):398-405. doi: 10.1002/jbt.21501. Epub 2013 May 28. |
kidney glutathione amount |
male |
0 days
| 8 |
|
108.4 |
ug/g |
4.56 |
12.9 |
liquid phase colorimetry |
|
0.0 |
0 |
|
|
76232 |
1542 |
Hsd:WI |
serum urea nitrogen level |
vehicle control condition (for 10 days) |
Prabhu VV, et al., Pharmacol Rep. 2013;65(4):980-90. |
blood urea nitrogen amount |
male |
0 days
| 6 |
|
69.64 |
mg/dl |
2.5 |
6.12 |
liquid phase colorimetry |
|
0.0 |
0 |
|
|
75976 |
1544 |
Hsd:WI |
serum urea nitrogen level |
silymarin (50 mg/kg/d) (for 10 days) then cisplatin (7.5 mg/kg) |
Prabhu VV, et al., Pharmacol Rep. 2013;65(4):980-90. |
blood urea nitrogen amount |
male |
0 days
| 6 |
|
75.2 |
mg/dl |
2.16 |
5.3 |
liquid phase colorimetry |
|
0.0 |
0 |
|
|
75979 |
1544 |
Crl:SD |
plasma glucose level |
controlled metformin content drinking water (350-500 mg/kg/d) (between 21 and 35 days) then controlled fructose content diet (66 %) (between 14 and 28 days) |
Verma S, et al., J Pharmacol Exp Ther. 1994 Dec;271(3):1334-7. |
blood glucose amount |
male |
0 days
| 8 |
|
102.6 |
mg/dl |
3.6 |
10.18 |
liquid phase colorimetry |
|
0.0 |
0 |
|
FT |
75921 |
1540 |
GK/Jcl |
serum total cholesterol level |
controlled cyclodextrin (CD)-clathrated hesperetin content diet (4.6 %) (for 28 days) |
Akiyama S, et al., Biosci Biotechnol Biochem. 2009 Dec;73(12):2779-82. doi: 10.1271/bbb.90576. Epub 2009 Dec 7. |
blood cholesterol amount |
male |
52 days
| 6 |
|
86.45 |
mg/dl |
3.98 |
9.75 |
liquid phase colorimetry |
|
0.0 |
0 |
|
|
103965 |
2884 |
GK/Jcl |
serum high density lipoprotein cholesterol level to serum total cholesterol level ratio |
controlled hesperidin content diet (1 %) (for 28 days) |
Akiyama S, et al., Biosci Biotechnol Biochem. 2009 Dec;73(12):2779-82. doi: 10.1271/bbb.90576. Epub 2009 Dec 7. |
blood cholesterol amount |
male |
52 days
| 6 |
|
0.94 |
null |
0.02 |
0.05 |
liquid phase colorimetry |
|
0.0 |
0 |
|
|
103968 |
2884 |
SD-Abcc6em2Qlju+/+ |
serum phosphate level |
standard diet |
Li Q, et al., J Invest Dermatol. 2017 May;137(5):1025-1032. doi: 10.1016/j.jid.2016.11.042. Epub 2017 Jan 19. |
blood phosphate amount |
male |
60 days-180 days |
5 |
|
7.0 |
mg/dl |
0.3 |
0.67 |
liquid phase colorimetry |
|
0.0 |
0 |
|
|
104642 |
2972 |
MWF |
renal filtration fraction |
cyclosporine A (50 ml/kg/d) (for 7 days) and lacidipine (1 mg/kg/d) (for 7 days) |
Fassi A, etal., Am J Kidney Dis. 1999 Feb;33(2):267-75. doi: 10.1016/s0272-6386(99)70299-4. |
glomerular filtration trait |
male |
133 days-147 days |
7 |
|
0.24 |
null |
0.03 |
0.08 |
liquid phase colorimetry |
|
0.0 |
0 |
|
|
110087 |
3163 |
Hsd:WI |
kidney superoxide dismutase to paraoxonase1 activity ratio |
phosphate buffered saline (for 25 days) |
Harisa GI J Biochem Mol Toxicol. 2013 Aug;27(8):398-405. doi: 10.1002/jbt.21501. Epub 2013 May 28. |
kidney superoxide dismutase activity |
male |
0 days
| 8 |
|
13.88 |
null |
0.5 |
1.41 |
liquid phase colorimetry |
|
0.0 |
0 |
|
|
76225 |
1542 |
Hsd:WI |
kidney superoxide dismutase activity to total protein level ratio |
cisplatin (3 mg/kg) (for 25 days) and benfotiamine (100 mg/kg/d) (for 25 days) |
Harisa GI J Biochem Mol Toxicol. 2013 Aug;27(8):398-405. doi: 10.1002/jbt.21501. Epub 2013 May 28. |
kidney superoxide dismutase activity |
male |
0 days
| 8 |
|
292.4 |
U/mg |
14.25 |
40.3 |
liquid phase colorimetry |
|
0.0 |
0 |
|
|
76202 |
1542 |
Hsd:WI |
kidney catalase activity to total protein level ratio |
1H-pyrazole (10 mg/kg/d) (for 10 days) then cisplatin (7.5 mg/kg) |
Prabhu VV, et al., Pharmacol Rep. 2013;65(4):980-90. |
catalase activity |
male |
0 days
| 6 |
|
23.2 |
nmol/mg |
0.29 |
0.7 |
liquid phase colorimetry |
|
0.0 |
0 |
|
|
76236 |
1544 |
Hsd:WI |
serum calcium level |
bisphenol A (250 mg/kg/d) (for 91 days) |
Yildiz N and Barlas N, Hum Exp Toxicol. 2013 Jul;32(7):675-86. doi: 10.1177/0960327112464796. |
blood calcium amount |
male |
119 days-126 days |
6 |
|
11.98 |
mg/dl |
0.18 |
0.45 |
liquid phase colorimetry |
|
0.0 |
0 |
|
|
76143 |
1545 |
Hsd:WI |
serum total bilirubin level |
octylphenol (125 mg/kg/d) (for 91 days) |
Yildiz N and Barlas N, Hum Exp Toxicol. 2013 Jul;32(7):675-86. doi: 10.1177/0960327112464796. |
blood bilirubin amount |
male |
119 days-126 days |
6 |
|
0.53 |
mg/dl |
0.08 |
0.21 |
liquid phase colorimetry |
|
0.0 |
0 |
|
|
76159 |
1545 |
Hsd:WI |
kidney glutathione level |
vehicle control condition (for 10 days) |
Prabhu VV, et al., Pharmacol Rep. 2013;65(4):980-90. |
kidney glutathione amount |
male |
0 days
| 6 |
|
12385.0 |
ug/g |
257.2 |
630.01 |
liquid phase colorimetry |
|
0.0 |
0 |
|
|
76238 |
1544 |
Hsd:WI |
kidney lipid peroxide level |
vehicle control condition (for 10 days) then cisplatin (7.5 mg/kg) |
Prabhu VV, et al., Pharmacol Rep. 2013;65(4):980-90. |
kidney lipid peroxide amount |
male |
0 days
| 6 |
|
1.51 |
nmol/mg |
0.03 |
0.08 |
liquid phase colorimetry |
|
0.0 |
0 |
|
|
76257 |
1544 |
SHR/OlaIpcv |
serum free fatty acids level |
fasting (for 16 hours) |
Seda O, et al., Physiol Genomics. 2005 Apr 14;21(2):243-52. Epub 2005 Feb 22. |
blood free fatty acid amount |
male |
0 days
| 6 |
|
1.28 |
mmol/l |
0.02 |
0.04 |
liquid phase colorimetry |
retroorbital plexus |
0.0 |
0 |
|
|
70288 |
1318 |
SD-Abcc6em2Qlju+/+ |
serum phosphate level |
standard diet |
Li Q, et al., J Invest Dermatol. 2017 May;137(5):1025-1032. doi: 10.1016/j.jid.2016.11.042. Epub 2017 Jan 19. |
blood phosphate amount |
female |
60 days-180 days |
5 |
|
5.9 |
mg/dl |
0.2 |
0.45 |
liquid phase colorimetry |
|
0.0 |
0 |
|
|
104643 |
2972 |
Hsd:WI |
kidney superoxide dismutase to glutathione peroxidase ratio |
cisplatin (3 mg/kg) (for 25 days) |
Harisa GI J Biochem Mol Toxicol. 2013 Aug;27(8):398-405. doi: 10.1002/jbt.21501. Epub 2013 May 28. |
kidney superoxide dismutase activity |
male |
0 days
| 8 |
|
35.78 |
null |
1.46 |
4.14 |
liquid phase colorimetry |
|
0.0 |
0 |
|
|
76223 |
1542 |
Hsd:WI |
kidney superoxide dismutase to paraoxonase1 activity ratio |
cisplatin (3 mg/kg) (for 25 days) and benfotiamine (100 mg/kg/d) (for 25 days) |
Harisa GI J Biochem Mol Toxicol. 2013 Aug;27(8):398-405. doi: 10.1002/jbt.21501. Epub 2013 May 28. |
kidney superoxide dismutase activity |
male |
0 days
| 8 |
|
19.72 |
null |
0.82 |
2.31 |
liquid phase colorimetry |
|
0.0 |
0 |
|
|
76228 |
1542 |
PD/Cub |
serum triglyceride level |
controlled sucrose content diet (for 7 days) then dexamethasone (0.03 mg/ml) (for 3 days) then fasting (for 16 hours) |
Seda O, et al., Physiol Genomics. 2005 Apr 14;21(2):243-52. Epub 2005 Feb 22. |
blood triglyceride amount |
male |
310 days
| 6 |
|
2412.4 |
mg/dl |
173.42 |
424.78 |
liquid phase colorimetry |
retroorbital plexus |
0.0 |
0 |
|
|
70219 |
1318 |
PD/Cub |
serum free fatty acids level |
controlled sucrose content diet (for 7 days) then dexamethasone (0.03 mg/ml) (for 3 days) then fasting (for 16 hours) |
Seda O, et al., Physiol Genomics. 2005 Apr 14;21(2):243-52. Epub 2005 Feb 22. |
blood free fatty acid amount |
male |
310 days
| 6 |
|
4.13 |
mmol/l |
0.12 |
0.3 |
liquid phase colorimetry |
retroorbital plexus |
0.0 |
0 |
|
|
70234 |
1318 |
Hsd:WI |
serum total protein level |
bisphenol A (250 mg/kg/d) (for 91 days) |
Yildiz N and Barlas N, Hum Exp Toxicol. 2013 Jul;32(7):675-86. doi: 10.1177/0960327112464796. |
blood total protein amount |
male |
119 days-126 days |
6 |
|
7.12 |
g/dl |
0.19 |
0.45 |
liquid phase colorimetry |
|
0.0 |
0 |
|
|
76127 |
1545 |
Crl:SD |
plasma glucose level |
controlled fructose content diet (66 %) (between 14 and 28 days) |
Verma S, et al., J Pharmacol Exp Ther. 1994 Dec;271(3):1334-7. |
blood glucose amount |
male |
63 days-77 days |
9 |
|
117.0 |
mg/dl |
3.6 |
10.8 |
liquid phase colorimetry |
|
0.0 |
0 |
|
F |
75855 |
1540 |
Hsd:WI |
kidney lipid peroxide level |
1H-pyrazole (10 mg/kg/d) (for 10 days) then cisplatin (7.5 mg/kg) |
Prabhu VV, et al., Pharmacol Rep. 2013;65(4):980-90. |
kidney lipid peroxide amount |
male |
0 days
| 6 |
|
0.83 |
nmol/mg |
0.04 |
0.09 |
liquid phase colorimetry |
|
0.0 |
0 |
|
|
76258 |
1544 |
Hsd:WI |
plasma uric acid level |
benfotiamine (100 mg/kg/d) (for 25 days) |
Harisa GI J Biochem Mol Toxicol. 2013 Aug;27(8):398-405. doi: 10.1002/jbt.21501. Epub 2013 May 28. |
blood uric acid amount |
male |
0 days
| 8 |
|
2.79 |
mg/dl |
0.18 |
0.52 |
liquid phase colorimetry |
|
0.0 |
0 |
|
|
75948 |
1542 |
Hsd:WI |
kidney catalase activity to total protein level ratio |
silymarin (50 mg/kg/d) (for 10 days) then cisplatin (7.5 mg/kg) |
Prabhu VV, et al., Pharmacol Rep. 2013;65(4):980-90. |
catalase activity |
male |
0 days
| 6 |
|
30.56 |
nmol/mg |
0.37 |
0.9 |
liquid phase colorimetry |
|
0.0 |
0 |
|
|
76237 |
1544 |
Hsd:WI |
serum triglyceride level |
vehicle control condition (for 91 days) |
Yildiz N and Barlas N, Hum Exp Toxicol. 2013 Jul;32(7):675-86. doi: 10.1177/0960327112464796. |
blood triglyceride amount |
male |
119 days-126 days |
5 |
|
156.94 |
mg/dl |
14.93 |
33.39 |
liquid phase colorimetry |
|
0.0 |
0 |
|
|
76135 |
1545 |
Hsd:WI |
serum triglyceride level |
octylphenol (125 mg/kg/d) (for 91 days) |
Yildiz N and Barlas N, Hum Exp Toxicol. 2013 Jul;32(7):675-86. doi: 10.1177/0960327112464796. |
blood triglyceride amount |
male |
119 days-126 days |
6 |
|
109.72 |
mg/dl |
16.57 |
40.58 |
liquid phase colorimetry |
|
0.0 |
0 |
|
|
76138 |
1545 |
Hsd:WI |
serum triglyceride level |
octylphenol (250 mg/kg/d) (for 91 days) |
Yildiz N and Barlas N, Hum Exp Toxicol. 2013 Jul;32(7):675-86. doi: 10.1177/0960327112464796. |
blood triglyceride amount |
male |
119 days-126 days |
6 |
|
111.38 |
mg/dl |
14.75 |
36.14 |
liquid phase colorimetry |
|
0.0 |
0 |
|
|
76139 |
1545 |
Hsd:WI |
serum albumin level |
octylphenol (125 mg/kg/d) (for 91 days) |
Yildiz N and Barlas N, Hum Exp Toxicol. 2013 Jul;32(7):675-86. doi: 10.1177/0960327112464796. |
blood albumin amount |
male |
119 days-126 days |
6 |
|
0.05 |
g/dl |
0.0 |
0.0 |
liquid phase colorimetry |
|
0.0 |
0 |
|
|
76152 |
1545 |
Hsd:WI |
serum lactate dehydrogenase activity level |
octylphenol (125 mg/kg/d) (for 91 days) |
Yildiz N and Barlas N, Hum Exp Toxicol. 2013 Jul;32(7):675-86. doi: 10.1177/0960327112464796. |
blood lactate dehydrogenase amount |
male |
119 days-126 days |
6 |
|
659.2 |
U/l |
70.1 |
171.7 |
liquid phase colorimetry |
|
0.0 |
0 |
|
|
76180 |
1545 |
Hsd:WI |
kidney superoxide dismutase activity to total protein level ratio |
phosphate buffered saline (for 25 days) |
Harisa GI J Biochem Mol Toxicol. 2013 Aug;27(8):398-405. doi: 10.1002/jbt.21501. Epub 2013 May 28. |
kidney superoxide dismutase activity |
male |
0 days
| 8 |
|
239.5 |
U/mg |
7.28 |
20.6 |
liquid phase colorimetry |
|
0.0 |
0 |
|
|
76199 |
1542 |
Hsd:WI |
kidney superoxide dismutase to glutathione peroxidase ratio |
benfotiamine (100 mg/kg/d) (for 25 days) |
Harisa GI J Biochem Mol Toxicol. 2013 Aug;27(8):398-405. doi: 10.1002/jbt.21501. Epub 2013 May 28. |
kidney superoxide dismutase activity |
male |
0 days
| 8 |
|
8.49 |
null |
0.4 |
1.14 |
liquid phase colorimetry |
|
0.0 |
0 |
|
|
76222 |
1542 |
Hsd:WI |
kidney superoxide dismutase to glutathione peroxidase ratio |
cisplatin (3 mg/kg) (for 25 days) and benfotiamine (100 mg/kg/d) (for 25 days) |
Harisa GI J Biochem Mol Toxicol. 2013 Aug;27(8):398-405. doi: 10.1002/jbt.21501. Epub 2013 May 28. |
kidney superoxide dismutase activity |
male |
0 days
| 8 |
|
18.63 |
null |
0.61 |
1.73 |
liquid phase colorimetry |
|
0.0 |
0 |
|
|
76224 |
1542 |
GK/Jcl |
serum high density lipoprotein cholesterol level to serum total cholesterol level ratio |
control condition |
Akiyama S, et al., Biosci Biotechnol Biochem. 2009 Dec;73(12):2779-82. doi: 10.1271/bbb.90576. Epub 2009 Dec 7. |
blood cholesterol amount |
male |
52 days
| 6 |
|
0.61 |
null |
0.02 |
0.05 |
liquid phase colorimetry |
|
0.0 |
0 |
|
|
103967 |
2884 |
GK/Jcl |
liver cholesterol level |
control condition |
Akiyama S, et al., Biosci Biotechnol Biochem. 2009 Dec;73(12):2779-82. doi: 10.1271/bbb.90576. Epub 2009 Dec 7. |
liver cholesterol amount |
male |
52 days
| 6 |
|
2.62 |
mg/g |
0.08 |
0.2 |
liquid phase colorimetry |
|
0.0 |
0 |
|
|
103975 |
2884 |
MWF |
renal plasma flow |
cyclosporine A (50 ml/kg/d) (for 7 days) and lacidipine (1 mg/kg/d) (for 7 days) |
Fassi A, etal., Am J Kidney Dis. 1999 Feb;33(2):267-75. doi: 10.1016/s0272-6386(99)70299-4. |
kidney plasma flow trait |
male |
133 days-147 days |
7 |
|
3.56 |
ml/min |
0.46 |
1.23 |
liquid phase colorimetry |
|
0.0 |
0 |
|
|
110084 |
3163 |
MWF |
renal filtration fraction |
cyclosporine A (50 ml/kg/d) (for 7 days) |
Fassi A, etal., Am J Kidney Dis. 1999 Feb;33(2):267-75. doi: 10.1016/s0272-6386(99)70299-4. |
glomerular filtration trait |
male |
133 days-147 days |
6 |
|
0.18 |
null |
0.02 |
0.04 |
liquid phase colorimetry |
|
0.0 |
0 |
|
|
110086 |
3163 |
Hsd:WI |
kidney superoxide dismutase activity to total protein level ratio |
vehicle control condition (for 10 days) |
Prabhu VV, et al., Pharmacol Rep. 2013;65(4):980-90. |
kidney superoxide dismutase activity |
male |
0 days
| 6 |
|
13.53 |
U/mg |
0.8 |
1.97 |
liquid phase colorimetry |
|
0.0 |
0 |
|
|
76187 |
1544 |
Hsd:WI |
kidney superoxide dismutase activity to total protein level ratio |
1H-pyrazole (10 mg/kg/d) (for 10 days) then cisplatin (7.5 mg/kg) |
Prabhu VV, et al., Pharmacol Rep. 2013;65(4):980-90. |
kidney superoxide dismutase activity |
male |
0 days
| 6 |
|
10.11 |
U/mg |
0.22 |
0.54 |
liquid phase colorimetry |
|
0.0 |
0 |
|
|
76189 |
1544 |
Hsd:WI |
plasma urea nitrogen level |
cisplatin (3 mg/kg) (for 25 days) |
Harisa GI J Biochem Mol Toxicol. 2013 Aug;27(8):398-405. doi: 10.1002/jbt.21501. Epub 2013 May 28. |
blood urea nitrogen amount |
male |
0 days
| 8 |
|
20.62 |
mmol/l |
1.27 |
3.61 |
liquid phase colorimetry |
|
0.0 |
0 |
|
|
75941 |
1542 |
Hsd:WI |
plasma uric acid level |
cisplatin (3 mg/kg) (for 25 days) |
Harisa GI J Biochem Mol Toxicol. 2013 Aug;27(8):398-405. doi: 10.1002/jbt.21501. Epub 2013 May 28. |
blood uric acid amount |
male |
0 days
| 8 |
|
7.67 |
mg/dl |
0.55 |
1.55 |
liquid phase colorimetry |
|
0.0 |
0 |
|
|
75949 |
1542 |
Hsd:WI |
serum total cholesterol level |
octylphenol (250 mg/kg/d) (for 91 days) |
Yildiz N and Barlas N, Hum Exp Toxicol. 2013 Jul;32(7):675-86. doi: 10.1177/0960327112464796. |
blood cholesterol amount |
male |
119 days-126 days |
6 |
|
61.15 |
mg/dl |
2.86 |
7.0 |
liquid phase colorimetry |
|
0.0 |
0 |
|
|
76134 |
1545 |
Hsd:WI |
serum triglyceride level |
bisphenol A (250 mg/kg/d) (for 91 days) |
Yildiz N and Barlas N, Hum Exp Toxicol. 2013 Jul;32(7):675-86. doi: 10.1177/0960327112464796. |
blood triglyceride amount |
male |
119 days-126 days |
6 |
|
92.87 |
mg/dl |
11.85 |
29.03 |
liquid phase colorimetry |
|
0.0 |
0 |
|
|
76137 |
1545 |
Hsd:WI |
serum calcium level |
octylphenol (250 mg/kg/d) (for 91 days) |
Yildiz N and Barlas N, Hum Exp Toxicol. 2013 Jul;32(7):675-86. doi: 10.1177/0960327112464796. |
blood calcium amount |
male |
119 days-126 days |
6 |
|
12.68 |
mg/dl |
0.31 |
0.76 |
liquid phase colorimetry |
|
0.0 |
0 |
|
|
76145 |
1545 |
Hsd:WI |
serum total bilirubin level |
vehicle control condition (for 91 days) |
Yildiz N and Barlas N, Hum Exp Toxicol. 2013 Jul;32(7):675-86. doi: 10.1177/0960327112464796. |
blood bilirubin amount |
male |
119 days-126 days |
5 |
|
0.96 |
mg/dl |
0.07 |
0.17 |
liquid phase colorimetry |
|
0.0 |
0 |
|
|
76156 |
1545 |
Crl:SD |
plasma glucose level |
controlled metformin content drinking water (350-500 mg/kg/d) then controlled fructose content diet (66 %) |
Verma S, et al., J Pharmacol Exp Ther. 1994 Dec;271(3):1334-7. |
blood glucose amount |
male |
42 days
| 10 |
|
104.4 |
mg/dl |
9.0 |
28.46 |
liquid phase colorimetry |
|
0.0 |
0 |
|
FT |
75861 |
1540 |
Hsd:WI |
kidney lipid peroxide level |
silymarin (50 mg/kg/d) (for 10 days) then cisplatin (7.5 mg/kg) |
Prabhu VV, et al., Pharmacol Rep. 2013;65(4):980-90. |
kidney lipid peroxide amount |
male |
0 days
| 6 |
|
0.88 |
nmol/mg |
0.02 |
0.06 |
liquid phase colorimetry |
|
0.0 |
0 |
|
|
76259 |
1544 |
BN/Cub |
serum free fatty acids level |
fasting (for 16 hours) |
Seda O, et al., Physiol Genomics. 2005 Apr 14;21(2):243-52. Epub 2005 Feb 22. |
blood free fatty acid amount |
male |
300 days
| 6 |
|
1.12 |
mmol/l |
0.08 |
0.2 |
liquid phase colorimetry |
retroorbital plexus |
0.0 |
0 |
|
|
70229 |
1318 |
SD-Abcc6em2Qlju+/- |
serum phosphate level to plasma pyrophosphate level ratio |
standard diet |
Li Q, et al., J Invest Dermatol. 2017 May;137(5):1025-1032. doi: 10.1016/j.jid.2016.11.042. Epub 2017 Jan 19. |
blood pyrophosphate amount |
female |
60 days-180 days |
5 |
|
710.9 |
null |
48.5 |
108.45 |
liquid phase colorimetry |
|
0.0 |
0 |
|
|
104663 |
2972 |
SD-Abcc6em2Qlju-/- |
serum phosphate level |
standard diet |
Li Q, et al., J Invest Dermatol. 2017 May;137(5):1025-1032. doi: 10.1016/j.jid.2016.11.042. Epub 2017 Jan 19. |
blood phosphate amount |
male |
60 days-180 days |
5 |
|
7.1 |
mg/dl |
0.5 |
1.12 |
liquid phase colorimetry |
|
0.0 |
0 |
|
|
104646 |
2972 |
Hsd:WI |
kidney glutathione peroxidase activity to glutathione reductase activity ratio |
benfotiamine (100 mg/kg/d) (for 25 days) |
Harisa GI J Biochem Mol Toxicol. 2013 Aug;27(8):398-405. doi: 10.1002/jbt.21501. Epub 2013 May 28. |
kidney glutathione peroxidase activity |
male |
0 days
| 8 |
|
54.88 |
null |
1.74 |
4.93 |
liquid phase colorimetry |
|
0.0 |
0 |
|
|
76214 |
1542 |
Hsd:WI |
kidney superoxide dismutase to paraoxonase1 activity ratio |
benfotiamine (100 mg/kg/d) (for 25 days) |
Harisa GI J Biochem Mol Toxicol. 2013 Aug;27(8):398-405. doi: 10.1002/jbt.21501. Epub 2013 May 28. |
kidney superoxide dismutase activity |
male |
0 days
| 8 |
|
12.45 |
null |
0.43 |
1.23 |
liquid phase colorimetry |
|
0.0 |
0 |
|
|
76226 |
1542 |
PD/Cub |
serum free fatty acids level |
controlled sucrose content diet (for 7 days) then fasting (for 16 hours) |
Seda O, et al., Physiol Genomics. 2005 Apr 14;21(2):243-52. Epub 2005 Feb 22. |
blood free fatty acid amount |
male |
307 days
| 6 |
|
1.56 |
mmol/l |
0.04 |
0.1 |
liquid phase colorimetry |
retroorbital plexus |
0.0 |
0 |
|
|
70230 |
1318 |
BN/Cub |
serum free fatty acids level |
controlled sucrose content diet (for 7 days) then fasting (for 16 hours) |
Seda O, et al., Physiol Genomics. 2005 Apr 14;21(2):243-52. Epub 2005 Feb 22. |
blood free fatty acid amount |
male |
307 days
| 6 |
|
1.26 |
mmol/l |
0.08 |
0.2 |
liquid phase colorimetry |
retroorbital plexus |
0.0 |
0 |
|
|
70231 |
1318 |
BN/Cub |
serum uric acid level |
controlled sucrose content diet (for 7 days) then fasting (for 16 hours) |
Seda O, et al., Physiol Genomics. 2005 Apr 14;21(2):243-52. Epub 2005 Feb 22. |
blood uric acid amount |
male |
307 days
| 6 |
|
101.8 |
umol/l |
4.78 |
11.7 |
liquid phase colorimetry |
retroorbital plexus |
0.0 |
0 |
|
|
70283 |
1318 |
Hsd:WI |
serum total protein level |
octylphenol (250 mg/kg/d) (for 91 days) |
Yildiz N and Barlas N, Hum Exp Toxicol. 2013 Jul;32(7):675-86. doi: 10.1177/0960327112464796. |
blood total protein amount |
male |
119 days-126 days |
6 |
|
7.37 |
g/dl |
0.12 |
0.29 |
liquid phase colorimetry |
|
0.0 |
0 |
|
|
76129 |
1545 |
Crl:SD |
plasma glucose level |
controlled metformin content drinking water (350-500 mg/kg/d) (between 21 and 35 days) then controlled fructose content diet (66 %) (between 14 and 28 days) |
Verma S, et al., J Pharmacol Exp Ther. 1994 Dec;271(3):1334-7. |
blood glucose amount |
male |
63 days-77 days |
10 |
|
111.6 |
mg/dl |
1.8 |
5.69 |
liquid phase colorimetry |
|
0.0 |
0 |
|
FT |
75857 |
1540 |
Hsd:WI |
serum urea nitrogen level |
vehicle control condition (for 91 days) |
Yildiz N and Barlas N, Hum Exp Toxicol. 2013 Jul;32(7):675-86. doi: 10.1177/0960327112464796. |
blood urea nitrogen amount |
male |
119 days-126 days |
5 |
|
77.76 |
mg/dl |
3.18 |
7.11 |
liquid phase colorimetry |
|
0.0 |
0 |
|
|
76164 |
1545 |
Hsd:WI |
serum urea nitrogen level |
bisphenol A (250 mg/kg/d) (for 91 days) |
Yildiz N and Barlas N, Hum Exp Toxicol. 2013 Jul;32(7):675-86. doi: 10.1177/0960327112464796. |
blood urea nitrogen amount |
male |
119 days-126 days |
6 |
|
72.5 |
mg/dl |
4.18 |
10.25 |
liquid phase colorimetry |
|
0.0 |
0 |
|
|
76166 |
1545 |
Hsd:WI |
serum creatinine level |
octylphenol (250 mg/kg/d) (for 91 days) |
Yildiz N and Barlas N, Hum Exp Toxicol. 2013 Jul;32(7):675-86. doi: 10.1177/0960327112464796. |
blood creatinine amount |
male |
119 days-126 days |
6 |
|
0.68 |
mg/dl |
0.03 |
0.08 |
liquid phase colorimetry |
|
0.0 |
0 |
|
|
76174 |
1545 |
Hsd:WI |
kidney paraoxonase1 activity to total protein level ratio |
cisplatin (3 mg/kg) (for 25 days) and benfotiamine (100 mg/kg/d) (for 25 days) |
Harisa GI J Biochem Mol Toxicol. 2013 Aug;27(8):398-405. doi: 10.1002/jbt.21501. Epub 2013 May 28. |
kidney paraoxonase 1 activity |
male |
0 days
| 8 |
|
14.83 |
U/mg |
0.43 |
1.21 |
liquid phase colorimetry |
|
0.0 |
0 |
|
|
76212 |
1542 |
Hsd:WI |
kidney superoxide dismutase to catalase activity ratio |
phosphate buffered saline (for 25 days) |
Harisa GI J Biochem Mol Toxicol. 2013 Aug;27(8):398-405. doi: 10.1002/jbt.21501. Epub 2013 May 28. |
kidney superoxide dismutase activity |
male |
0 days
| 8 |
|
1.98 |
null |
0.07 |
0.21 |
liquid phase colorimetry |
|
0.0 |
0 |
|
|
76217 |
1542 |
Hsd:WI |
kidney paraoxonase1 activity to total protein level ratio |
benfotiamine (100 mg/kg/d) (for 25 days) |
Harisa GI J Biochem Mol Toxicol. 2013 Aug;27(8):398-405. doi: 10.1002/jbt.21501. Epub 2013 May 28. |
kidney paraoxonase 1 activity |
male |
0 days
| 8 |
|
19.45 |
U/mg |
0.75 |
2.13 |
liquid phase colorimetry |
|
0.0 |
0 |
|
|
76210 |
1542 |
Hsd:WI |
kidney glutathione level |
vehicle control condition (for 10 days) then cisplatin (7.5 mg/kg) |
Prabhu VV, et al., Pharmacol Rep. 2013;65(4):980-90. |
kidney glutathione amount |
male |
0 days
| 6 |
|
7882.76 |
ug/g |
178.16 |
436.39 |
liquid phase colorimetry |
|
0.0 |
0 |
|
|
76239 |
1544 |
Hsd:WI |
plasma creatinine level |
cisplatin (3 mg/kg) (for 25 days) |
Harisa GI J Biochem Mol Toxicol. 2013 Aug;27(8):398-405. doi: 10.1002/jbt.21501. Epub 2013 May 28. |
blood creatinine amount |
male |
0 days
| 8 |
|
2.85 |
mg/dl |
0.25 |
0.71 |
liquid phase colorimetry |
|
0.0 |
0 |
|
|
75945 |
1542 |
Hsd:WI |
kidney superoxide dismutase activity to total protein level ratio |
vehicle control condition (for 10 days) then cisplatin (7.5 mg/kg) |
Prabhu VV, et al., Pharmacol Rep. 2013;65(4):980-90. |
kidney superoxide dismutase activity |
male |
0 days
| 6 |
|
8.13 |
U/mg |
0.79 |
1.94 |
liquid phase colorimetry |
|
0.0 |
0 |
|
|
76188 |
1544 |
Hsd:WI |
serum urea nitrogen level |
vehicle control condition (for 10 days) then cisplatin (7.5 mg/kg) |
Prabhu VV, et al., Pharmacol Rep. 2013;65(4):980-90. |
blood urea nitrogen amount |
male |
0 days
| 6 |
|
96.11 |
mg/dl |
1.91 |
4.69 |
liquid phase colorimetry |
|
0.0 |
0 |
|
|
75977 |
1544 |
Hsd:WI |
kidney superoxide dismutase to glutathione peroxidase ratio |
phosphate buffered saline (for 25 days) |
Harisa GI J Biochem Mol Toxicol. 2013 Aug;27(8):398-405. doi: 10.1002/jbt.21501. Epub 2013 May 28. |
kidney superoxide dismutase activity |
male |
0 days
| 8 |
|
8.66 |
null |
0.41 |
1.15 |
liquid phase colorimetry |
|
0.0 |
0 |
|
|
76221 |
1542 |
Hsd:WI |
kidney glutathione level |
phosphate buffered saline (for 25 days) |
Harisa GI J Biochem Mol Toxicol. 2013 Aug;27(8):398-405. doi: 10.1002/jbt.21501. Epub 2013 May 28. |
kidney glutathione amount |
male |
0 days
| 8 |
|
123.7 |
ug/g |
1.78 |
5.04 |
liquid phase colorimetry |
|
0.0 |
0 |
|
|
76229 |
1542 |
Hsd:WI |
kidney glutathione level |
cisplatin (3 mg/kg) (for 25 days) |
Harisa GI J Biochem Mol Toxicol. 2013 Aug;27(8):398-405. doi: 10.1002/jbt.21501. Epub 2013 May 28. |
kidney glutathione amount |
male |
0 days
| 8 |
|
58.72 |
ug/g |
3.78 |
10.7 |
liquid phase colorimetry |
|
0.0 |
0 |
|
|
76231 |
1542 |
Hsd:WI |
kidney glutathione level |
silymarin (50 mg/kg/d) (for 10 days) then cisplatin (7.5 mg/kg) |
Prabhu VV, et al., Pharmacol Rep. 2013;65(4):980-90. |
kidney glutathione amount |
male |
0 days
| 6 |
|
9864.97 |
ug/g |
200.74 |
491.71 |
liquid phase colorimetry |
|
0.0 |
0 |
|
|
76241 |
1544 |
GK/Jcl |
serum high density lipoprotein cholesterol level to serum total cholesterol level ratio |
controlled cyclodextrin (CD)-clathrated hesperetin content diet (4.6 %) (for 28 days) |
Akiyama S, et al., Biosci Biotechnol Biochem. 2009 Dec;73(12):2779-82. doi: 10.1271/bbb.90576. Epub 2009 Dec 7. |
blood cholesterol amount |
male |
52 days
| 6 |
|
0.9 |
null |
0.07 |
0.17 |
liquid phase colorimetry |
|
0.0 |
0 |
|
|
103969 |
2884 |
Jcl:WI |
liver cholesterol level |
control condition |
Akiyama S, et al., Biosci Biotechnol Biochem. 2009 Dec;73(12):2779-82. doi: 10.1271/bbb.90576. Epub 2009 Dec 7. |
liver cholesterol amount |
male |
52 days
| 6 |
|
1.88 |
mg/g |
0.15 |
0.37 |
liquid phase colorimetry |
|
0.0 |
0 |
|
|
103974 |
2884 |
SD-Abcc6em2Qlju-/- |
serum phosphate level |
standard diet |
Li Q, et al., J Invest Dermatol. 2017 May;137(5):1025-1032. doi: 10.1016/j.jid.2016.11.042. Epub 2017 Jan 19. |
blood phosphate amount |
female |
60 days-180 days |
5 |
|
5.9 |
mg/dl |
0.2 |
0.45 |
liquid phase colorimetry |
|
0.0 |
0 |
|
|
104647 |
2972 |
SD-Abcc6em2Qlju+/- |
serum phosphate level |
standard diet |
Li Q, et al., J Invest Dermatol. 2017 May;137(5):1025-1032. doi: 10.1016/j.jid.2016.11.042. Epub 2017 Jan 19. |
blood phosphate amount |
male |
60 days-180 days |
5 |
|
7.1 |
mg/dl |
0.6 |
1.34 |
liquid phase colorimetry |
|
0.0 |
0 |
|
|
104644 |
2972 |
MWF |
renal plasma flow |
cyclosporine A (50 ml/kg/d) (for 7 days) |
Fassi A, etal., Am J Kidney Dis. 1999 Feb;33(2):267-75. doi: 10.1016/s0272-6386(99)70299-4. |
kidney plasma flow trait |
male |
133 days-147 days |
6 |
|
2.58 |
ml/min |
0.1 |
0.24 |
liquid phase colorimetry |
|
0.0 |
0 |
|
|
110083 |
3163 |
DA/BklArbNsi |
inflammatory exudate nitric oxide level |
room temperature (14 ml) (for 3 days) then room temperature (10 ml) (for 3 days) then carrageenan (1 ml) (for 6 hours) |
Laragione T, et al., J Immunol. 2007 Feb 15;178(4):2344-51. |
nitric oxide amount |
female |
56 days-98 days |
9 |
median |
0.11 |
umol/l |
|
|
liquid phase colorimetry |
subcutaneous interscapular cavity |
0.0 |
0 |
Griess test |
inflammatory exudate nitric oxide measurement |
68403 |
332 |
Hsd:WI |
plasma urea nitrogen level |
cisplatin (3 mg/kg) (for 25 days) and benfotiamine (100 mg/kg/d) (for 25 days) |
Harisa GI J Biochem Mol Toxicol. 2013 Aug;27(8):398-405. doi: 10.1002/jbt.21501. Epub 2013 May 28. |
blood urea nitrogen amount |
male |
0 days
| 8 |
|
14.48 |
mmol/l |
0.88 |
2.49 |
liquid phase colorimetry |
|
0.0 |
0 |
|
|
75942 |
1542 |
Hsd:WI |
plasma creatinine level |
benfotiamine (100 mg/kg/d) (for 25 days) |
Harisa GI J Biochem Mol Toxicol. 2013 Aug;27(8):398-405. doi: 10.1002/jbt.21501. Epub 2013 May 28. |
blood creatinine amount |
male |
0 days
| 8 |
|
0.27 |
mg/dl |
0.02 |
0.05 |
liquid phase colorimetry |
|
0.0 |
0 |
|
|
75944 |
1542 |
Hsd:WI |
plasma uric acid level |
phosphate buffered saline (for 25 days) |
Harisa GI J Biochem Mol Toxicol. 2013 Aug;27(8):398-405. doi: 10.1002/jbt.21501. Epub 2013 May 28. |
blood uric acid amount |
male |
0 days
| 8 |
|
2.97 |
mg/dl |
0.18 |
0.51 |
liquid phase colorimetry |
|
0.0 |
0 |
|
|
75947 |
1542 |
Hsd:WI |
serum albumin level |
bisphenol A (250 mg/kg/d) (for 91 days) |
Yildiz N and Barlas N, Hum Exp Toxicol. 2013 Jul;32(7):675-86. doi: 10.1177/0960327112464796. |
blood albumin amount |
male |
119 days-126 days |
6 |
|
0.04 |
g/dl |
0.0 |
0.0 |
liquid phase colorimetry |
|
0.0 |
0 |
|
|
76151 |
1545 |
Hsd:WI |
serum creatinine level |
octylphenol (125 mg/kg/d) (for 91 days) |
Yildiz N and Barlas N, Hum Exp Toxicol. 2013 Jul;32(7):675-86. doi: 10.1177/0960327112464796. |
blood creatinine amount |
male |
119 days-126 days |
6 |
|
0.55 |
mg/dl |
0.04 |
0.11 |
liquid phase colorimetry |
|
0.0 |
0 |
|
|
76173 |
1545 |
Hsd:WI |
serum total cholesterol level |
octylphenol (125 mg/kg/d) (for 91 days) |
Yildiz N and Barlas N, Hum Exp Toxicol. 2013 Jul;32(7):675-86. doi: 10.1177/0960327112464796. |
blood cholesterol amount |
male |
119 days-126 days |
6 |
|
62.85 |
mg/dl |
3.03 |
7.43 |
liquid phase colorimetry |
|
0.0 |
0 |
|
|
76133 |
1545 |
Hsd:WI |
kidney glutathione peroxidase activity to glutathione reductase activity ratio |
phosphate buffered saline (for 25 days) |
Harisa GI J Biochem Mol Toxicol. 2013 Aug;27(8):398-405. doi: 10.1002/jbt.21501. Epub 2013 May 28. |
kidney glutathione peroxidase activity |
male |
0 days
| 8 |
|
59.12 |
null |
1.93 |
5.47 |
liquid phase colorimetry |
|
0.0 |
0 |
|
|
76213 |
1542 |
SD-Abcc6em2Qlju-/- |
serum phosphate level to plasma pyrophosphate level ratio |
standard diet |
Li Q, et al., J Invest Dermatol. 2017 May;137(5):1025-1032. doi: 10.1016/j.jid.2016.11.042. Epub 2017 Jan 19. |
blood pyrophosphate amount |
female |
60 days-180 days |
5 |
|
1925.5 |
null |
479.2 |
1071.52 |
liquid phase colorimetry |
|
0.0 |
0 |
|
|
104665 |
2972 |
Crl:SD |
plasma glucose level |
controlled metformin content drinking water (350-500 mg/kg/d) (between 21 and 35 days) then controlled fructose content diet (66 %) (between 14 and 28 days) then insulin (2 U/kg/d) (for 14 days) |
Verma S, et al., J Pharmacol Exp Ther. 1994 Dec;271(3):1334-7. |
blood glucose amount |
male |
0 days
| 8 |
|
82.8 |
mg/dl |
7.2 |
20.36 |
liquid phase colorimetry |
|
0.0 |
0 |
|
FT |
75922 |
1540 |